: iStockAnalyst.com Symbols Feed

Bullish Stocks To Watch For The Week Of August 31, 2009

Mon, 31 Aug 2009 17:55:14 GMT

In this post is a list of 13 stocks that I'll be keeping an eye on for the week ahead. All of the stocks mentioned in this post are stocks which have broken out to the upside on unusually large volume. The table below shows the company, ticker, Friday's per share % increase, and Friday's volume increase (% increased compared to 50 day average).[More...]

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

Mon, 31 Aug 2009 21:55:00 GMT

BERWYN, Pa., Aug. 31 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that on August 25, 2009, it received a letter from The NASDAQ Stock Market notifying the Company that, based on its Form 10-Q for the period ended June 30, 2009, NASDAQ has determined that the Company's stockholders' equity does not comply with the minimum $2.5 million stockholders' equity requirement for continued listing on The NASDAQ Capital Market as required by NASDAQ Marketplace Rule 5550(b)(1).
About Encorium Group, Inc.
Factors that could cause or contribute to such differences include, but are not limited to: (i) the risk that we may not have sufficient funds to operate our business; (ii)our success in attracting new business and retaining existing clients and projects; (iii) the size, duration and timing of clinical trials we are currently managing may change unexpectedly; (iv) the termination, delay or cancellation of clinical trials we are currently managing could cause revenues and cash-on-hand to decline unexpectedly; (v) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to manage these trials; (vi) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (vii) the ability to maintain profit margins in a competitive marketplace; (viii) our ability to attract and retain qualified personnel; (ix) the sensitivity of our business to general economic conditions; (x) other economic, competitive, governmental and technological factors affecting our operations, markets, products, services and prices; (xi) announced awards received from existing and potential customers are not definitive until fully negotiated contracts are executed by the parties; (xii) our backlog may not be indicative of future results and may not generate the revenues expected; and (xiii) uncertainties regarding the availability of additional capital and continued listing of our common stock on Nasdaq.

: iStockAnalyst.com Symbols Feed

Bullish Stocks To Watch For The Week Of August 31, 2009

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

Encorium Announces Receipt of Letters From Nasdaq Regarding Its Second Quarter 2009 Form 10-Q Filing

InvestorSoup.com Issues Technical Trading Overview for Power3 Medical Products Inc.

Encorium Reports Second Quarter 2009 Financial Results

Encorium Group Completes Sale of Its U.S. Business to Pierrel Research USA; Announces Management Changes

Encorium Group Updates Expected Timeframe With Respect to the Sale of Its U.S. Business

Encorium Group Amends LOI With Respect to the Sale of Its U.S. Business;

Encorium Reports First Quarter 2009 Financial Results

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

Encorium Group Enters into Non-Binding Letters of Intent

Form 4/A ENCORIUM GROUP INC For: Dec 30 Filed by: Lindevall Kai Eugen Harald (10K)

Form 4 ENCORIUM GROUP INC For: Dec 30 Filed by: Koskelo Ilari (10K)

Form 3 ENCORIUM GROUP INC For: Jan 08 Filed by: Koskelo Eeva-Kaarina (10K)

Form 4 ENCORIUM GROUP INC For: Dec 30 Filed by: Lindevall Kai Eugen Harald (10K)

Form 4 ENCORIUM GROUP INC For: Nov 13 Filed by: Fatheazam Shahab (10K)

Form 4 ENCORIUM GROUP INC For: Nov 13 Filed by: Morra David (10K)

Form 4 ENCORIUM GROUP INC For: Nov 13 Filed by: Manninen Petri Mikael (10K)

Form 4 ENCORIUM GROUP INC For: Nov 13 Filed by: Laitinen Sari (10K)

Form 3 ENCORIUM GROUP INC For: Nov 07 Filed by: Laitinen Sari (10K)

Form 3 ENCORIUM GROUP INC For: Oct 19 Filed by: Koskelo Ilari (10K)